ESTD.: 1947 | TYPE: Government | AFFILIATION: WHO | RECOGNITION: MCI
Immanuel Kant Baltic Federal University is one of 10 federal universities in the Russian Federation. The university was awarded federal status on December 30, 2010. From 2010–2015, the university implemented a major expansion program valued at RUB 5 billion. In 2015, the Long-Term Development Strategy of Immanuel Kant Baltic Federal University won the International Competitiveness Award for Russian Universities.
Immanuel Kant Baltic Federal University is a leading educational institute in Russia’s westernmost region. The university currently offers over 300 secondary, higher, additional, and post-graduate professional educational programs. The university’s infrastructure includes 53 buildings. Over the past 5 years, the total area of the university area has expanded by 3.5 times. The university has its own Clinical Diagnostic Center. Over the past 5 years, our R&D funding has increased by 3.5 times.
Immanuel Kant Baltic Federal University, an innovative university in the Russian Federation, strives to maintain and further develop the academic traditions of its predecessor – Albertina Koenigsberg University. The history of Albertina, one of Europe’s oldest universities, dates back more than 460 years. Over the years, its instructors and lecturers have included: Johann Hamann, Johann Herder, Friedrich Bessel, Friedrich Jakobi, Ferdinand von Lindemann, Adolf Hurwitz, David Hilbert, and Herman von Helmholtz; the founder of Lithuanian literature Kristijonas Donelaitis studied theology at the university; and the writer and composer E.T.A. Hoffman attended lectures in philosophy. The greatest figure in the history of Koenigsberg University is undoubtedly Immanuel Kant, the great philosopher who was once a Russian citizen. His name forever tied Koenigsberg and the university with the cultural history of all mankind and became a landmark of the region.
The university sees its mission as developing a leading national university in new areas and activities based on breakthroughs in biomedicine and neuro- and nano-technologies, setting industry standards, and producing highly qualified professionals who are competitive on the global market. Our priority is R&D in biomedicine and neurotechnologies, which deliver products and services aimed at extending a high-quality life.